|
|
|
||
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
The
|
TIMBER PHARMACEUTICALS, INC.
|
||
Date: November 17, 2023
|
By:
|
/s/ John Koconis
|
Name:
|
John Koconis
|
|
Title:
|
Chief Executive Officer
|
Document And Entity Information |
Nov. 17, 2023 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | TIMBER PHARMACEUTICALS, INC. |
Document, Type | 8-K |
Document, Period End Date | Nov. 17, 2023 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 001-37411 |
Entity, Tax Identification Number | 59-3843182 |
Entity, Address, Address Line One | 3 Mountainview Road, Suite 100, |
Entity, Address, City or Town | Warren |
Entity, Address, State or Province | NJ |
Entity, Address, Postal Zip Code | 07059 |
City Area Code | 908 |
Local Phone Number | 636-7160 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | TMBR |
Security Exchange Name | NYSE |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0001504167 |
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end
\T+!1T?+O10V#[KO3EO#C_W.=QYYI?]*@TEN?8X@ $ #+V^8OMW) MRXJYD;< @Q]A)DNG &$\.G$@74,0=\(2)?!BC MIZ.1FL"Q\C=X?#_O_^]>.KSYW@E,!6S!?UVH%&XZRWT6X5SS1Q-(2C7OK>SK M#BSY9B5@3X6 30'>\6JT6*_=-\)M%_ '-D4$L! A0#% @ 16AQ5Q>:I637! YBP !4 M ( !E@, '1M8G(M,C R,S$Q,3=?9&5F+GAM;%!+ 0(4 Q0 M ( $5H<5??)_RN^04 $0\ 5 " : ( !T;6)R+3(P M,C,Q,3$W7VQA8BYX;6Q02P$"% ,4 " !%:'%7_BYSVW,$ !^+0 %0 M @ ',#@ =&UB &UL4$L! A0#% M @ 16AQ5T>F5(#Z#@ 3%L !0 ( !